Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trial

Kiriaki Papaikonomou; Caroline Frisendahl; Alistair Williams; Kristina Gemzell‐Danielsson

doi:10.1016/j.ejogrb.2020.06.056

Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trial

Kiriaki Papaikonomou, Caroline Frisendahl, Alistair Williams, Kristina Gemzell‐Danielsson

In: European Journal of Obstetrics & Gynecology and Reproductive Biology · 2020 · vol. 252 , pp. 330–335 · doi:10.1016/j.ejogrb.2020.06.056 · PMID:32653606 · W3037278355

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This randomized controlled trial investigated the effects of the levonorgestrel intrauterine system on the endometrium following long-term mifepristone exposure.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (37)

Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone via openalex
Effect of long-term treatment with low-dose mifepristone on the endometrium via openalex
Progestagens and anti-progestagens for pain associated with endometriosis via openalex
Progestagens and anti-progestagens for pain associated with endometriosis via openalex
Progesterone receptor modulators for endometriosis via openalex
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS via openalex
Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety via openalex
Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies via openalex
Unscheduled vaginal bleeding with progestin-only contraceptive use via openalex
doi:10.1097/pgp.0b013e318251035b via openalex
doi:10.1038/modpathol.2008.19 via openalex
doi:10.1056/nejmoa1103182 via openalex
doi:10.2147/ijwh.s33125 via openalex
doi:10.1002/14651858.cd001324.pub5 via openalex
doi:10.1016/j.contraception.2008.08.003 via openalex
doi:10.1093/humrep/dep100 via openalex
doi:10.1016/j.contraception.2015.12.015 via openalex
doi:10.1016/j.cct.2017.02.002 via openalex
doi:10.1093/humrep/15.9.1969 via openalex
doi:10.1056/nejmoa1103180 via openalex
doi:10.1016/j.contraception.2018.05.020 via openalex
doi:10.1016/j.fertnstert.2014.02.008 via openalex
doi:10.1007/978-1-4419-0489-8 via openalex
W6639007481 via openalex
doi:10.1002/14651858.cd001324.pub6 via openalex
doi:10.1016/j.fertnstert.2018.10.012 via openalex
doi:10.1002/jcph.998 via openalex
W6732527681 via openalex
W6741581601 via openalex
W7073579906 via openalex
doi:10.1016/s0140-6736(16)31333-2 via openalex
doi:10.1093/humrep/dey296 via openalex
doi:10.1016/j.ijgo.2010.08.009 via openalex
doi:10.1093/humrep/17.10.2588 via openalex
doi:10.1016/j.contraception.2014.08.006 via openalex
doi:10.1007/978-1-4614-3165-7 via openalex
doi:10.1093/humrep/dew359 via openalex

SciLite annotations

chemicals 9

levonorgestrel mifepristone progestin mifepristone levonorgestrel mifepristone mifepristone mifepristone progestin

organisms 1

noordeloos 2009062

Source provenance

openalex: last seen: 2026-05-11T06:22:51.059792+00:00
scilite: last seen: 2026-05-18T04:26:01.642840+00:00

License: CC0 · commercial use OK

[1] Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone via openalex

[2] Effect of long-term treatment with low-dose mifepristone on the endometrium via openalex

[3] Progestagens and anti-progestagens for pain associated with endometriosis via openalex

[4] Progestagens and anti-progestagens for pain associated with endometriosis via openalex

[5] Progesterone receptor modulators for endometriosis via openalex

[6] Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS via openalex

[7] Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety via openalex

[8] Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies via openalex

[9] Unscheduled vaginal bleeding with progestin-only contraceptive use via openalex

[10] doi:10.1097/pgp.0b013e318251035b via openalex

[11] doi:10.1038/modpathol.2008.19 via openalex

[12] doi:10.1056/nejmoa1103182 via openalex

[13] doi:10.2147/ijwh.s33125 via openalex

[14] doi:10.1002/14651858.cd001324.pub5 via openalex

[15] doi:10.1016/j.contraception.2008.08.003 via openalex

[16] doi:10.1093/humrep/dep100 via openalex

[17] doi:10.1016/j.contraception.2015.12.015 via openalex

[18] doi:10.1016/j.cct.2017.02.002 via openalex

[19] doi:10.1093/humrep/15.9.1969 via openalex

[20] doi:10.1056/nejmoa1103180 via openalex

[21] doi:10.1016/j.contraception.2018.05.020 via openalex

[22] doi:10.1016/j.fertnstert.2014.02.008 via openalex

[23] doi:10.1007/978-1-4419-0489-8 via openalex

[24] W6639007481 via openalex

[25] doi:10.1002/14651858.cd001324.pub6 via openalex

[26] doi:10.1016/j.fertnstert.2018.10.012 via openalex

[27] doi:10.1002/jcph.998 via openalex

[28] W6732527681 via openalex

[29] W6741581601 via openalex

[30] W7073579906 via openalex

[31] doi:10.1016/s0140-6736(16)31333-2 via openalex

[32] doi:10.1093/humrep/dey296 via openalex

[33] doi:10.1016/j.ijgo.2010.08.009 via openalex

[34] doi:10.1093/humrep/17.10.2588 via openalex

[35] doi:10.1016/j.contraception.2014.08.006 via openalex

[36] doi:10.1007/978-1-4614-3165-7 via openalex

[37] doi:10.1093/humrep/dew359 via openalex